Hostname: page-component-7c8c6479df-8mjnm Total loading time: 0 Render date: 2024-03-29T04:55:27.472Z Has data issue: false hasContentIssue false

Pindolol augmentation of antidepressant therapy

Published online by Cambridge University Press:  03 January 2018

R. H. McAllister-Williams
Affiliation:
Department of Psychiatry and Neuroscience, University of Newcastle upon Tyne, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH
A. H. Young
Affiliation:
Department of Psychiatry and Neuroscience, University of Newcastle upon Tyne, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

Blier, P. & de Montigny, C. (1994) Current advances in the treatment of depression. Trends in Pharmacological Sciences, 15, 220226.Google Scholar
Clifford, E. M., Gartside, S. E., Umbers, V., et al (1998) Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT (IA) autoreceptor in vivo. British Journal of Pharmacology, 124, 206212.Google Scholar
McAskill, R., Mir, S. & Taylor, D. (1998) Pindolol augmentation of antidepressant therapy. British Journal of Psychiatry, 173, 203208.Google Scholar
Power, A. C. & Cowen, P. J. (1992) Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression. Molecular Aspects of Medicine. 13, 205220.Google Scholar
Rabiner, E. A., Sargent, P. A., Gunn, R. N., et al (1998) Imaging pindolol binding to 5-HTLA receptors in man using PET. International Journal of Neuropsychopharmacology, I (suppl. I), S65.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.